Our Spin-off CasInvent Pharma Raises €1.3 Million from Foreign Investors
A unique investment has been made in the university spin-off company CasInvent Pharma, which is developing compounds with anticancer properties. The KHAN Technology Transfer Fund I and i&i Biotech Fund invested €1.3 million in the company. With this funding, CasInvent Pharma will be strengthening the development and preclinical testing of a compound for the treatment of leukaemia.